Group One Trading
DNA icon

Group One Trading’s Ginkgo Bioworks DNA Stock Holding History

Group One Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
32,910
+26,893
+447% +$225K ﹤0.01% 3880
2026
Q1 		$36.9K Sell
6,017
-8,442
-58% -$70.2K ﹤0.01% 5498
2025
Q4 		$120K Buy
14,459
+8,375
+138% +$90.2K ﹤0.01% 4843
2025
Q3 		$88.7K Buy
+6,084
New +$72.8K ﹤0.01% 5454
2025
Q1 		– Sell
-62,046
Closed -$632K – 7754
2024
Q4 		$609K Buy
+62,046
New +$532K ﹤0.01% 3007
2024
Q3 		– Sell
-28,907
Closed -$290K – 6770
2024
Q2 		$387K Buy
28,907
+5,878
+26% +$175K ﹤0.01% 2809
2024
Q1 		$1.07M Buy
23,029
+14,352
+165% +$743K ﹤0.01% 2024
2023
Q4 		$587K Sell
8,677
-431
-5% -$26.4K ﹤0.01% 2934
2023
Q3 		$659K Buy
9,108
+4,789
+111% +$383K ﹤0.01% 2644
2023
Q2 		$321K Sell
4,319
-75
-2% -$4.44K ﹤0.01% 3477
2023
Q1 		$234K Sell
4,394
-1,267
-22% -$80.3K ﹤0.01% 3522
2022
Q4 		$383K Buy
5,661
+1,678
+42% +$154K ﹤0.01% 3289
2022
Q3 		$497K Sell
3,983
-4,070
-51% -$485K ﹤0.01% 3241
2022
Q2 		$767K Buy
+8,053
New +$982K ﹤0.01% 2998

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Group One Trading's DNA Position: Q2 2026 in Review

Group One Trading increased its Ginkgo Bioworks (DNA) stake by 447% in Q2 2026, buying an estimated $225K and bringing the position to 32,910 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3880.

Group One Trading first reported a position in DNA in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.07M in Q1 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Group One Trading held 32,910 shares of Ginkgo Bioworks worth $326K as of Q2 2026.
  • Group One Trading bought 26,893 Ginkgo Bioworks shares in Q2 2026, an estimated $225K.
  • Ginkgo Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3880 holding.
  • Group One Trading first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 14 quarters since.
  • Group One Trading's Ginkgo Bioworks position peaked at $1.07M in Q1 2024.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.